Global Rivaroxaban Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Rivaroxaban Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Rivaroxaban Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 2.5 mg
  • 1.2.3 10 mg
  • 1.2.4 15 mg
  • 1.2.5 20 mg
• 1.3 Market by Application
  • 1.3.1 Global Rivaroxaban Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Acute Coronary Syndrome (ACS)
  • 1.3.3 Venous Thromboembolism (VTE)
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Rivaroxaban Market Size Estimates and Forecasts
  • 2.1.1 Global Rivaroxaban Revenue 2020-2031
  • 2.1.2 Global Rivaroxaban Sales 2020-2031
• 2.2 Rivaroxaban Market Size by Region: 2024 Versus 2031
• 2.3 Rivaroxaban Sales by Region (2020-2031)
  • 2.3.1 Global Rivaroxaban Sales by Region: 2020-2025
  • 2.3.2 Global Rivaroxaban Sales Forecast by Region (2026-2031)
  • 2.3.3 Global Rivaroxaban Sales Market Share by Region (2020-2031)
• 2.4 Rivaroxaban Market Estimates and Projections by Region (2026-2031)
  • 2.4.1 Global Rivaroxaban Revenue by Region: 2020-2025
  • 2.4.2 Global Rivaroxaban Revenue Forecast by Region (2026-2031)
  • 2.4.3 Global Rivaroxaban Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Rivaroxaban Sales by Type (2020-2031)
    • 3.1.1.1 Global Rivaroxaban Sales Volume by Type (2020-2031)
    • 3.1.1.2 Global Rivaroxaban Sales Market Share by Type (2020-2031)
  • 3.1.2 Global Rivaroxaban Revenue by Type (2020-2031)
    • 3.1.2.1 Global Rivaroxaban Revenue by Type (2020-2031)
    • 3.1.2.2 Global Rivaroxaban Revenue Market Share by Type (2020-2031)
  • 3.1.3 Rivaroxaban Average Selling Price (ASP) by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Rivaroxaban Sales by Application (2020-2031)
    • 3.2.1.1 Global Rivaroxaban Sales Volume by Application (2020-2031)
    • 3.2.1.2 Global Rivaroxaban Sales Market Share by Application (2020-2031)
  • 3.2.2 Global Rivaroxaban Revenue by Application (2020-2031)
    • 3.2.2.1 Global Rivaroxaban Revenue by Application (2020-2031)
    • 3.2.2.2 Global Rivaroxaban Revenue Market Share by Application (2020-2031)
  • 3.2.3 Rivaroxaban Average Selling Price (ASP) by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 2.5 mg of Rivaroxaban Revenue Market Share by Application
  • 3.3.2 10 mg of Rivaroxaban Revenue Market Share by Application
  • 3.3.3 15 mg of Rivaroxaban Revenue Market Share by Application
  • 3.3.4 20 mg of Rivaroxaban Revenue Market Share by Application

4 Global Rivaroxaban by Manufacturers

• 4.1 Global Top Rivaroxaban Manufacturers by Sales (2020-2025)
  • 4.1.1 Global Rivaroxaban Sales by Manufacturer (2020-2025)
  • 4.1.2 Global Rivaroxaban Sales Market Share by Manufacturer (2020-2025)
• 4.2 Global Top Rivaroxaban Manufacturers by Revenue (2020-2025)
  • 4.2.1 Global Rivaroxaban Revenue by Manufacturer (2020-2025)
  • 4.2.2 Global Rivaroxaban Revenue Share by Manufacturer (2020-2025)
• 4.3 Global Rivaroxaban Price by Manufacturer (2020-2025)
• 4.4 Competitive Landscape
  • 4.4.1 Key Rivaroxaban Manufacturers Covered: Ranking by Revenue
  • 4.4.2 Global Rivaroxaban Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.4.3 Global Rivaroxaban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.5 Global Rivaroxaban Manufacturing Base Distribution, Product Type
  • 4.5.1 Rivaroxaban Manufacturers Manufacturing Base Distribution, Headquarters
  • 4.5.2 Date of International Manufacturers Enter into Rivaroxaban Market
  • 4.5.3 Manufacturers Rivaroxaban Product Type and Application
  • 4.5.4 2.5 mg Market Sales of Rivaroxaban by Manufacturer
• 4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 Bayer
  • 5.1.1 Bayer Company Information
  • 5.1.2 Bayer Description, Business Overview
  • 5.1.3 Bayer Rivaroxaban Products Offered
  • 5.1.4 Bayer Rivaroxaban Sales, Revenue and Gross Margin (2020-2025)
  • 5.1.5 Bayer Rivaroxaban Sales by Product in 2024
  • 5.1.6 Bayer Rivaroxaban Sales by Application in 2024
  • 5.1.7 Bayer Rivaroxaban Sales by Geographic Area in 2024
  • 5.1.8 Bayer Recent Developments
• 5.2 J&J
  • 5.2.1 J&J Company Information
  • 5.2.2 J&J Description, Business Overview
  • 5.2.3 J&J Rivaroxaban Products Offered
  • 5.2.4 J&J Rivaroxaban Sales, Revenue and Gross Margin (2020-2025)
  • 5.2.5 J&J Rivaroxaban Sales by Product in 2024
  • 5.2.6 J&J Rivaroxaban Sales by Application in 2024
  • 5.2.7 J&J Rivaroxaban Sales by Geographic Area in 2024
  • 5.2.8 J&J Recent Developments

6 North America

• 6.1 North America Rivaroxaban Market Size YoY Growth 2020-2031
• 6.2 North America Rivaroxaban Market Facts & Figures by Country
  • 6.2.1 North America Rivaroxaban Sales by Country (2020-2031)
  • 6.2.2 North America Rivaroxaban Revenue by Country (2020-2031)
• 6.3 North America Rivaroxaban Sales by Type (2020-2025)
• 6.4 North America Rivaroxaban Sales by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Rivaroxaban Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Rivaroxaban Market Facts & Figures by Region
  • 7.2.1 Asia-Pacific Rivaroxaban Sales by Region (2020-2031)
  • 7.2.2 Asia-Pacific Rivaroxaban Revenue by Region (2020-2031)
• 7.3 Asia-Pacific Rivaroxaban Sales by Type (2020-2025)
• 7.4 Asia-Pacific Rivaroxaban Sales by Application (2020-2025)

8 Europe

• 8.1 Europe Rivaroxaban Market Size YoY Growth 2020-2031
• 8.2 Europe Rivaroxaban Market Facts & Figures by Country
  • 8.2.1 Europe Rivaroxaban Sales by Country (2020-2031)
  • 8.2.2 Europe Rivaroxaban Revenue by Country (2020-2031)
• 8.3 Europe Rivaroxaban Sales by Type (2020-2025)
• 8.4 Europe Rivaroxaban Sales by Application (2020-2025)

9 Latin America

• 9.1 Latin America Rivaroxaban Market Size YoY Growth 2020-2031
• 9.2 Latin America Rivaroxaban Market Facts & Figures by Country
  • 9.2.1 Latin America Rivaroxaban Sales by Country (2020-2031)
  • 9.2.2 Latin America Rivaroxaban Revenue by Country (2020-2031)
• 9.3 Latin America Rivaroxaban Sales by Type (2020-2025)
• 9.4 Latin America Rivaroxaban Sales by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Rivaroxaban Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Rivaroxaban Market Facts & Figures by Country
  • 10.2.1 Middle East and Africa Rivaroxaban Sales by Country (2020-2031)
  • 10.2.2 Middle East and Africa Rivaroxaban Revenue by Country (2020-2031)
• 10.3 Middle East and Africa Rivaroxaban Sales by Type (2020-2025)
• 10.4 Middle East and Africa Rivaroxaban Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Rivaroxaban Supply Chain Analysis
• 11.2 Rivaroxaban Key Raw Materials and Upstream Suppliers
• 11.3 Rivaroxaban Clients Analysis
• 11.4 Rivaroxaban Sales Channel and Sales Model Analysis
  • 11.4.1 Rivaroxaban Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Rivaroxaban Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Rivaroxaban Distributors

12 Rivaroxaban Market Dynamics

• 12.1 Rivaroxaban Industry Trends
• 12.2 Rivaroxaban Market Drivers
• 12.3 Rivaroxaban Market Challenges
• 12.4 Rivaroxaban Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Rivaroxaban Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Rivaroxaban Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Rivaroxaban Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Rivaroxaban Sales by Region (2020-2025) & (K Units)

Table 5. Global Rivaroxaban Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Rivaroxaban Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Rivaroxaban Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Rivaroxaban Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Rivaroxaban Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Rivaroxaban Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Rivaroxaban Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Rivaroxaban Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Rivaroxaban Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Rivaroxaban Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Rivaroxaban Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Rivaroxaban Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Rivaroxaban Sales Share by Manufacturer (2020-2025)

Table 18. Rivaroxaban Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Rivaroxaban Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Rivaroxaban Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Rivaroxaban Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Rivaroxaban Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Rivaroxaban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rivaroxaban as of 2024)

Table 24. Rivaroxaban Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Rivaroxaban Market

Table 26. Manufacturers Rivaroxaban Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Bayer Company Information

Table 29. Bayer Description and Business Overview

Table 30. Bayer Rivaroxaban Product

Table 31. Bayer Rivaroxaban Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Bayer Sales Proportion of Rivaroxaban by Product in 2024

Table 33. Bayer Sales Proportion of Rivaroxaban by Application in 2024

Table 34. Bayer Sales Proportion of Rivaroxaban by Geographic Area in 2024

Table 35. Bayer Recent Developments

Table 36. J&J Company Information

Table 37. J&J Description and Business Overview

Table 38. J&J Rivaroxaban Product

Table 39. J&J Rivaroxaban Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. J&J Sales Proportion of Rivaroxaban by Product in 2024

Table 41. J&J Sales Proportion of Rivaroxaban by Application in 2024

Table 42. J&J Sales Proportion of Rivaroxaban by Geographic Area in 2024

Table 43. J&J Recent Developments

Table 44. North America Rivaroxaban Sales by Country (2020-2025) & (K Units)

Table 45. North America Rivaroxaban Sales by Country (2026-2031) & (K Units)

Table 46. North America Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)

Table 47. North America Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)

Table 48. North America Rivaroxaban Sales by Type (2020-2025) & (K Units)

Table 49. North America Rivaroxaban Sales by Application (2020-2025) & (K Units)

Table 50. Asia-Pacific Rivaroxaban Sales by Region (2020-2025) & (K Units)

Table 51. Asia-Pacific Rivaroxaban Sales by Region (2026-2031) & (K Units)

Table 52. Asia-Pacific Rivaroxaban Revenue by Region (2020-2025) & (US$ Million)

Table 53. Asia-Pacific Rivaroxaban Revenue by Region (2026-2031) & (US$ Million)

Table 54. Asia-Pacific Rivaroxaban Sales by Type (2020-2025) & (K Units)

Table 55. Asia-Pacific Rivaroxaban Sales by Application (2020-2025) & (K Units)

Table 56. Europe Rivaroxaban Sales by Country (2020-2025) & (K Units)

Table 57. Europe Rivaroxaban Sales by Country (2026-2031) & (K Units)

Table 58. Europe Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)

Table 59. Europe Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)

Table 60. Europe Rivaroxaban Sales by Type (2020-2025) & (K Units)

Table 61. Europe Rivaroxaban Sales by Application (2020-2025) & (K Units)

Table 62. Latin America Rivaroxaban Sales by Country (2020-2025) & (K Units)

Table 63. Latin America Rivaroxaban Sales by Country (2026-2031) & (K Units)

Table 64. Latin America Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)

Table 65. Latin America Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)

Table 66. Latin America Rivaroxaban Sales by Type (2020-2025) & (K Units)

Table 67. Latin America Rivaroxaban Sales by Application (2020-2025) & (K Units)

Table 68. Middle East and Africa Rivaroxaban Sales by Country (2020-2025) & (K Units)

Table 69. Middle East and Africa Rivaroxaban Sales by Country (2026-2031) & (K Units)

Table 70. Middle East and Africa Rivaroxaban Revenue by Country (2020-2025) & (US$ Million)

Table 71. Middle East and Africa Rivaroxaban Revenue by Country (2026-2031) & (US$ Million)

Table 72. Middle East and Africa Rivaroxaban Sales by Type (2020-2025) & (K Units)

Table 73. Middle East and Africa Rivaroxaban Sales by Application (2020-2025) & (K Units)

Table 74. Rivaroxaban Key Raw Materials, Industry Status and Trend

Table 75. Rivaroxaban Key Raw Materials and Upstream Suppliers

Table 76. Rivaroxaban Clients Status and Trend

Table 77. Rivaroxaban Typical Clients

Table 78. Rivaroxaban Distributors

Table 79. Rivaroxaban Market Trends

Table 80. Rivaroxaban Market Drivers

Table 81. Rivaroxaban Market Challenges

Table 82. Rivaroxaban Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Rivaroxaban Product Picture

Figure 2. Global Rivaroxaban Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Rivaroxaban Sales Market Share by Type in 2024 & 2031

Figure 4. 2.5 mg Product Picture

Figure 5. 10 mg Product Picture

Figure 6. 15 mg Product Picture

Figure 7. 20 mg Product Picture

Figure 8. Global Rivaroxaban Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Rivaroxaban Sales Market Share by Application in 2024 & 2031

Figure 10. Acute Coronary Syndrome (ACS)

Figure 11. Venous Thromboembolism (VTE)

Figure 12. Rivaroxaban Report Years Considered

Figure 13. Global Rivaroxaban Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Rivaroxaban Market Size 2020-2031 (US$ Million)

Figure 15. Global Rivaroxaban Sales 2020-2031 (K Units)

Figure 16. Global Rivaroxaban Sales Market Share Forecast by Region (2020-2031)

Figure 17. Global Rivaroxaban Revenue Market Share by Region (2020-2031)

Figure 18. Global Rivaroxaban Sales Market Share Forecast by Type (2020-2031)

Figure 19. Global Rivaroxaban Revenue Market Share Forecast by Type (2020-2031)

Figure 20. Rivaroxaban Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 21. Global Rivaroxaban Sales Market Share Forecast by Application (2020-2031)

Figure 22. Global Rivaroxaban Revenue Market Share Forecast by Application (2020-2031)

Figure 23. Rivaroxaban Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 24. 2.5 mg of Rivaroxaban Revenue Market Share by Application, 2024 VS 2031

Figure 25. 10 mg of Rivaroxaban Revenue Market Share by Application, 2024 VS 2031

Figure 26. 15 mg of Rivaroxaban Revenue Market Share by Application, 2024 VS 2031

Figure 27. 20 mg of Rivaroxaban Revenue Market Share by Application, 2024 VS 2031

Figure 28. Global Rivaroxaban Sales Share by Manufacturer in 2024

Figure 29. Rivaroxaban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 30. 2.5 mg Market Sales Proportion by Manufacturer in 2024

Figure 31. 10 mg Market Sales Proportion by Manufacturer in 2024

Figure 32. 15 mg Market Sales Proportion by Manufacturer in 2024

Figure 33. 20 mg Market Sales Proportion by Manufacturer in 2024

Figure 34. North America Rivaroxaban Revenue 2020-2031 (US$ Million)

Figure 35. North America Rivaroxaban Sales Market Share by Type (2020-2025)

Figure 36. North America Rivaroxaban Sales Market Share by Application (2020-2025)

Figure 37. Asia-Pacific Rivaroxaban Revenue 2020-2031 (US$ Million)

Figure 38. Asia-Pacific Rivaroxaban Sales Market Share by Region (2020-2031)

Figure 39. Asia-Pacific Rivaroxaban Revenue Market Share by Region (2020-2031)

Figure 40. Asia-Pacific Rivaroxaban Sales Market Share by Type (2020-2025)

Figure 41. Asia-Pacific Rivaroxaban Sales Market Share by Application (2020-2025)

Figure 42. Europe Rivaroxaban Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Europe Rivaroxaban Sales Market Share by Country (2020-2031)

Figure 44. Europe Rivaroxaban Revenue Market Share by Country (2020-2031)

Figure 45. Europe Rivaroxaban Sales Market Share by Type (2020-2025)

Figure 46. Europe Rivaroxaban Sales Market Share by Application (2020-2025)

Figure 47. Latin America Rivaroxaban Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Latin America Rivaroxaban Sales Market Share by Country (2020-2031)

Figure 49. Latin America Rivaroxaban Revenue Market Share by Country (2020-2025)

Figure 50. Latin America Rivaroxaban Sales Market Share by Type (2020-2025)

Figure 51. Latin America Rivaroxaban Sales Market Share by Application (2020-2025)

Figure 52. Middle East and Africa Rivaroxaban Revenue Growth Rate 2020-2031 (US$ Million)

Figure 53. Middle East and Africa Rivaroxaban Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Rivaroxaban Revenue Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Rivaroxaban Sales Market Share by Type (2020-2025)

Figure 56. Middle East and Africa Rivaroxaban Sales Market Share by Application (2020-2025)

Figure 57. Rivaroxaban Supply Chain (Upstream and Downstream Market)

Figure 58. Global Production Market Share of Rivaroxaban Raw Materials by Region in 2024

Figure 59. Rivaroxaban Distribution Channels

Figure 60. Global Rivaroxaban Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 61. Global Rivaroxaban Percentage 2020-2031: Online Sales VS Offline Sales

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed